Tradestie Institutional Equity Comparison Engine
AIM vs GNPX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GNPX Overall Edge
GNPX Captures Institutional Edge (2โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Genprex, Inc. Common Stock (GNPX) driven by superior Growth & Margin, Momentum & Technical while AIM counters with relative strength in Valuation. Fundamentally, AIM trades at 2.0x Forward P/E with -11724.2% operating margin (+4.0% YoY revenue) versus GNPX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AIM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
AIM
AIM 2.0x vs GNPX N/M Fwd P/E
Growth & Margin Winner
GNPX
Op Margin -11724.2% vs 0.0% ยท YoY +4.0% vs +0.0%
Momentum & Technical Winner
GNPX
1Y -91.4% vs -56.6% ยท 52W Pos 0% vs 11%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AIM
NYSE American
AIM ImmunoTech Inc.
Biological Products, (No Disgnostic Substances)
$0.11
-4.5% 1D
Market Cap
$4.8M
1M Return
-28.82%
1Y Return
-91.38%
Forward P/E
2.0x
Unified AI Score
39.4 / 100
SELL
Tech 25.0
Fund 43.0
Flow 50.0
Mom 59.0
GNPX
NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap
$2.2M
1M Return
-26.77%
1Y Return
-56.59%
Forward P/E
N/M
Unified AI Score
42.2 / 100
HOLD
Tech 25.0
Fund 47.0
Flow 50.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AIM -91.38%
GNPX -56.59%
Spread: +34.79 pp (GNPX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AIM TTM Op. Margin: -11724.2%
GNPX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AIM vs GNPX. Trailing 12-month operating profitability (AIM -11724.2% vs GNPX 0.0%) and valuation multiples (AIM 2.0x vs GNPX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AIM | GNPX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.8M | $2.2M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 2.0x | N/M | Lower Multiple | AIM |
| Forward P/E Ratio Valuation | 2.0x | N/M | Lower Multiple | AIM |
| Revenue Growth (YoY) Growth | +4.0% | +0.0% | Higher Growth | AIM |
| Operating Margin (TTM) Profitability | -11724.2% | 0.0% | Higher Margin | GNPX |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -2382.3% | -233.7% | Higher ROE | GNPX |
| 52-Week Range Position Momentum | 0% ($0โ$2) | 11% ($0โ$10) | Stronger Trend | GNPX |
| Beta / 30D Volatility Risk Regime | 0.56ฮฒ ยท 76% Vol | -4.68ฮฒ ยท 96% Vol | Lower Realized Risk | AIM |
| Unified Institutional Score Composite Signal | 39.4 / 100 (SELL) | 42.2 / 100 (HOLD) | Higher Composite | GNPX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AIM vs GNPX Buy Guide
AIM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GNPX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AIM nor GNPX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.